Age-specific prevalence of human papilloma virus infection among Nigerian women

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Akarolo Anthony, Sally N ^a,b   Famooto, Ayo O ^b   Dareng, Eileen O ^b   Olaniyan, Olayinka B ^c   Offiong, Richard ^d   Wheeler, Cosette M ^e   Adebamowo, Clement A ^a,b,f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

^c NATIONAL HOSPITAL   (Nigeria)

^d UNIVERSITY OF ABUJA   (Nigeria)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

HPV infection; Nigeria; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AFRICA; AGE; EARLY DIAGNOSIS; FEMALE; GENETICS; GENOTYPE; HUMAN; MIDDLE AGED; NIGERIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA; AGE FACTORS; EARLY DETECTION OF CANCER; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NIGERIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84902931415     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-656     Document Type: Article

References (29)

1. Papillomavirus infections-a major cause of human cancers. Hausen H, Biochim Biophys Acta 1996 1288 55 F78 8876633
2. Global burden of human papillomavirus and related diseases. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S, Vaccine 2012 30 Suppl 5 12 F23 23199955
3. The epidemiology of human papillomavirus infections. Baseman JG, Koutsky LA, J Clin Virol 2005 32 Suppl 1 16 S24 15753008
4. Prevalence of HPV infection among females in the United States. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE, JAMA 2007 297 813 819 10.1001/jama.297.8.813 17327523 (Pubitemid 46333946)
5. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ, Int J Cancer 2000 87 221 227 10.1002/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2 10861478 (Pubitemid 30434349)
6. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Castellsague X, Schneider A, Kaufmann AM, Bosch FX, Gynecol Oncol 2009 115 15 S23 10.1016/j.ygyno.2009.09.021 19819540
7. Age-specific prevalence of infection with human papillomavirus in females: a global review. Smith JS, Melendy A, Rana RK, Pimenta JM, J Adolesc Health 2008 43 5 S25 S25 e21-41 18809145
8. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection. Temmerman M, Tyndall MW, Kidula N, Claeys P, Muchiri L, Quint W, Int J Gynaecol Obstet 1999 65 171 181 10.1016/S0020-7292(99)00043-0 10405062 (Pubitemid 29258304)
9. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. Serwadda D, Wawer MJ, Shah KV, Sewankambo NK, Daniel R, Li C, Lorincz A, Meehan MP, Wabwire-Mangen F, Gray RH, J Infect Dis 1999 180 1316 1319 10.1086/315026 10479163 (Pubitemid 30070219)
10. Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe. Womack SD, Chirenje ZM, Blumenthal PD, Gaffikin L, McGrath JA, Chipato T, Ngwalle E, Shah KV, BJOG 2000 107 33 38 10.1111/j.1471-0528.2000.tb11576.x 10645859 (Pubitemid 30042723)
11. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Munoz N, Snijders PJ, Meijer CJ, Franceschi S, Br J Cancer 2004 90 638 645 10.1038/sj.bjc.6601515 14760378 (Pubitemid 38297204)
12. Human papillomavirus genotypes in rural Mozambique. Castellsague X, Menendez C, Loscertales MP, Kornegay JR, dos Santos F, Gomez-Olive FX, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch FX, Alonso P, Lancet 2001 358 1429 1430 10.1016/S0140-6736(01)06523-0 11705494 (Pubitemid 33055750)
13. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Xi LF, Toure P, Critchlow CW, Hawes SE, Dembele B, Sow PS, Kiviat NB, Int J Cancer 2003 103 803 809 10.1002/ijc.10876 12516102 (Pubitemid 36110238)
14. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC, J Natl Cancer Inst 2000 92 818 825 10.1093/jnci/92.10.818 10814677 (Pubitemid 30368038)
15. A population-based, cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria. Clarke MA, Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Wacholder S, Burk RD, Schiffman M, Infect Agent Cancer 2011 6 12 10.1186/1750-9378-6-12 21801395
16. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, Hutchinson M, Wacholder S, Harford J, Soliman AS, Burk RD, Schiffman M, Int J Cancer 2012 130 2111 2117 10.1002/ijc.26211 21630264
17. Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Wall SR, Scherf CF, Morison L, Hart KW, West B, Ekpo G, Fiander AN, Man S, Gelder CM, Walraven G, Borysiewicz LK, Br J Cancer 2005 93 1068 1076 10.1038/sj.bjc.6602736 16106268 (Pubitemid 41548404)
18. The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda. Veldhuijzen NJ, Braunstein SL, Vyankandondera J, Ingabire C, Ntirushwa J, Kestelyn E, Tuijn C, Wit FW, Umutoni A, Uwineza M, Crucitti T, van de Wijgert JH, BMC Infect Dis 2011 11 333 10.1186/1471-2334-11-333 22136570
19. Nigeria Demographic and Health Survey. NPC, Book Nigeria Demographic and Health Survey City 2008
20. Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology. Castle PE, Sadorra M, Garcia F, Holladay EB, Kornegay J, J Clin Microbiol 2006 44 3915 3917 10.1128/JCM.01305-06 16971652 (Pubitemid 44737228)
21. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. Coutlee F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, Boyle S, Hankins C, Vezina S, Cote P, Macleod J, Voyer H, Forest P, Walmsley S, Franco E, J Clin Microbiol 2006 44 1998 2006 10.1128/JCM.00104-06 16757590 (Pubitemid 43902145)
22. Validation of an automated detection platform for use with the roche linear array human papillomavirus genotyping test. Stevens MP, Garland SM, Tabrizi SN, J Clin Microbiol 2008 46 3813 3816 10.1128/JCM.01169-08 18784316
23. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test. van Hamont D, van Ham MA, Bakkers JM, Massuger LF, Melchers WJ, J Clin Microbiol 2006 44 3122 3129 10.1128/JCM.00517-06 16954236 (Pubitemid 44413740)
24. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Schiffman M, Clifford G, Buonaguro FM, Infect Agent Cancer 2009 4 8 10.1186/1750-9378-4-8 19486508
25. Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJ, Meijer CJ, Clifford GM, Infect Agent Cancer 2010 5 24 10.1186/1750-9378-5-24 21129194
26. Distribution of human papillomavirus in a family planning population in nairobi, kenya. De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, Vansteelandt S, Quint W, Kleter B, Van Marck E, Temmerman M, Sex Transm Dis 2003 30 137 142 10.1097/00007435-200302000-00009 12567172 (Pubitemid 36184362)
27. Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa. Hanisch RA, Sow PS, Toure M, Dem A, Dembele B, Toure P, Winer RL, Hughes JP, Gottlieb GS, Feng Q, Kiviat NB, Hawes SE, J Clin Virol 2013 58 696 702 10.1016/j.jcv.2013.10.012 24210330
28. HIV associated high-risk HPV infection among Nigerian women. Akarolo-Anthony SN, Al-Mujtaba M, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, Wheeler CM, Adebamowo CA, BMC Infect Dis 2013 13 521 10.1186/1471-2334-13-521 24192311
29. Obesity and the likelihood of sexual behavioral risk factors for HPV and cervical cancer. Wee CC, Huang A, Huskey KW, McCarthy EP, Obesity (Silver Spring) 2008 16 2552 2555 10.1038/oby.2008.394 18719677